Apollo Hospitals Enterprise Limited (APOLLOHOSP)
🎯 Key Takeaways
- Apollo Hospitals Enterprise Limited is in a strategic growth and transformation phase, marked by leadership continuity, capital market activity, and expansion in digital health and hospital infrastructure. Management is actively repositioning the company through demergers, strategic investments, and digital innovation, while maintaining strong financial performance and shareholder returns.
- Revenue grew 2% QoQ to ₹6,606 in Q4FY26.
- ⚠️ Key risks include execution challenges in integrating and scaling digital health initiatives, potential integration complexities from the Apollo Healt
📖 The Story
Apollo Hospitals Enterprise Limited is in a strategic growth and transformation phase, marked by leadership continuity, capital market activity, and expansion in digital health and hospital infrastructure. Management is actively repositioning the company through demergers, strategic investments, and digital innovation, while maintaining strong financial performance and shareholder returns.
📰 What's Happening
Recent developments include the re-appointment of Dr. Prathap C Reddy as Executive Chairman for two years (June 25, 2026–June 24, 2028) and shareholder approval for a ₹7,500 million non-convertible debenture placement, as disclosed in the AGM filing on August 1, 2026. The company also completed a composite scheme of arrangement involving demerger and restructuring among Apollo Healthco, Keimed, and Apollo Healthtech entities, finalized in June 2026 and approved by NCLT, enabling board reconstitution and share listing. Additionally, a conference call on August 13, 2026, was scheduled to discuss unaudited Q1 FY27 results, with senior leadership including Managing Director Suneeta Reddy and Group CFO A. Krishnan engaging investors directly.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,086 | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 |
| Operating Profit | 712 | 854 | 825 | 831 | 892 | 996 | 999 | 1,055 |
| OPM % | 13.3% | 14.6% | 13.8% | 13.8% | 14.6% | 14.9% | 14.9% | 15.3% |
| Net Profit | 316 | 396 | 379 | 415 | 441 | 494 | 516 | 551 |
| EPS | ₹21.23 | ₹26.34 | ₹25.89 | ₹27.10 | ₹30.10 | ₹33.19 | ₹34.94 | ₹36.82 |
The company has demonstrated consistent revenue and margin growth over the past eight quarters, with revenue rising from ₹5,086 crore in Q1FY25 to ₹6,606 crore in Q4FY26, and operating margins expanding from 13.3% to 15.3%. Net profit and EPS have grown steadily, reflecting operational efficiency and scale. This growth trajectory aligns with management's stated focus on expanding bed capacity (1,000 new beds planned in FY26-27) and scaling digital health initiatives, suggesting that recent financial performance is underpinned by both organic expansion and strategic investments.
🔮 Management Outlook & What's Next
Management has indicated a forward-looking strategy centered on digital transformation, AI-driven healthcare innovation, and expansion in maternity and fertility care through a proposed combination with Cloudnine. The re-appointment of Dr. Prathap C Reddy ensures leadership continuity amid these strategic shifts. While no explicit forward guidance was provided in the latest filings beyond operational plans, the company emphasized its focus on sustainable growth, digital health scalability, and capital allocation efficiency during the AGM on August 25, 2026.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | 2024-2025 | 2025-2026 | 2025-2026 | 2025-2026 | 2025-2026 |
|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 |
| Reserves | 8,140 | — | 9,021 | — | 9,408 |
| Borrowings | 5,275 | — | 5,341 | — | 5,659 |
| Total Liabilities | 12,005 | 6,405 | 12,397 | 6,480 | 12,222 |
| Fixed Assets | 9,816 | — | 9,965 | — | 11,039 |
| Investments | 2,263 | — | 2,780 | — | 1,922 |
| Total Assets | 20,657 | 21,331 | 21,950 | 22,447 | 22,197 |
The balance sheet shows a stable capital structure with equity of ₹72 crore and reserves of ₹9,408 crore in the latest filing, supporting a strong asset base of ₹22,197 crore. Borrowings have increased to ₹5,659 crore, indicating active capital deployment, likely linked to expansion and debenture-funded initiatives. Despite rising debt, equity buffers remain robust, and the company continues to maintain a disciplined approach to capital allocation, balancing growth investments with dividend commitments and shareholder-friendly policies.
💰 Cash Flow Statement (₹ Cr)
| Item | 2020-2021 | 2020-2021 |
|---|---|---|
| Operating | +265 | +1,273 |
| Investing | +352 | -872 |
| Financing | -461 | -340 |
| Net Cash Flow | — | — |
⚖️ Peer Comparison — Healthcare Services
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | 1.16 L Cr | 64.5 | 20.5% | 21.9% | 0.64 |
| Max Healthcare Institute Limited | 1.02 L Cr | 101.2 | — | — | — |
| Fortis Healthcare Limited | 72,752 | 94.6 | — | — | — |
| Aster DM Healthcare Limited | 39,048 | 7.1 | — | — | — |
| Narayana Hrudayalaya Ltd. | 37,625 | 47.7 | — | — | — |
| Global Health Limited | 33,405 | 65.8 | — | — | — |
| Krishna Institute of Medical Sciences Limited | 30,477 | 80.3 | — | — | — |
| Dr. Lal Path Labs Ltd. | 26,871 | 63.6 | — | — | — |
| Syngene International Limited | 18,295 | 36.3 | — | — | — |
| Dr. Agarwal's Health Care Limited | 14,266 | 88.8 | 14.9% | 6.8% | 0.13 |
⚠️ Risk Factors
Key risks include execution challenges in integrating and scaling digital health initiatives, potential integration complexities from the Apollo Healthtech demerger and restructuring, and margin pressure from aggressive expansion in new segments like maternity and fertility care. Additionally, rising debt levels to fund debenture placements and infrastructure expansion could constrain financial flexibility if growth trajectories slow or market conditions deteriorate.
📋 Recent Filings
-
🟡 Board Meeting 1 August 2026Apollo Hospitals' 45th AGM on August 25, 2026, will adopt FY2026 financial statements, declare a ₹10 interim dividend (200% of ₹5 face value), and re-...
-
🔴 annual report 1 August 2026Apollo Hospitals Enterprise Limited announced its 45th Annual General Meeting (AGM) scheduled for August 25, 2026, via video conferencing, to adopt FY...
-
🔴 Financial Results 18 July 2026Apollo Hospitals Enterprise Limited announced a conference call on August 13, 2026 at 3:00 PM IST to discuss unaudited Q1 FY27 financial results, foll...
-
Announcement 3 July 2026Apollo Hospitals confirmed that securities were dematerialized and updated on NSE and BSE for the quarter ended June 30, 2026, as required under SEBI ...
-
🔴 Corporate Action 26 June 2026Apollo Hospitals Enterprise Limited announced that all resolutions for its composite scheme of arrangement involving demerger, amalgamation and rebran...
-
Financial Results 25 June 2026Apollo Hospitals announced that its trading window will close on 1 July 2026 for 48 hours following the release of unaudited quarterly results ending ...
-
🔴 Corporate Action 24 June 2026Apollo Hospitals announced the completion of its scheme of arrangement meeting held on June 24, 2026, where secured, unsecured creditors and equity sh...
-
🔴 Corporate Action 19 June 2026Apollo Hospitals announced a composite scheme of arrangement involving its subsidiary Apollo Healthtech Limited, detailing promoter commitments to wai...
-
🔴 Announcement 16 June 2026No summary available
-
🔴 Corporate Action 15 June 2026Apollo Hospitals announced a composite scheme of arrangement involving Apollo Healthtech Limited, Transferor Company 1, and Transferor Company 2, seek...
🧠 Analyst's Read
Apollo Hospitals is executing a clear transformation strategy anchored in leadership stability, digital innovation, and infrastructure expansion, supported by strong and growing financial performance. Investors should monitor the progress of the Cloudnine combination, the deployment of debenture proceeds, and management's ability to scale digital health solutions profitably, as these will be critical determinants of future growth sustainability.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-03.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when APOLLOHOSP files new disclosures
Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APOLLOHOSP — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research